1. Home
  2. ADAP vs NEON Comparison

ADAP vs NEON Comparison

Compare ADAP & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • NEON
  • Stock Information
  • Founded
  • ADAP 2008
  • NEON 1997
  • Country
  • ADAP United Kingdom
  • NEON Sweden
  • Employees
  • ADAP N/A
  • NEON N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • NEON Industrial Machinery/Components
  • Sector
  • ADAP Health Care
  • NEON Technology
  • Exchange
  • ADAP Nasdaq
  • NEON Nasdaq
  • Market Cap
  • ADAP 158.6M
  • NEON 161.3M
  • IPO Year
  • ADAP 2015
  • NEON 2007
  • Fundamental
  • Price
  • ADAP $0.56
  • NEON $9.61
  • Analyst Decision
  • ADAP Strong Buy
  • NEON Strong Buy
  • Analyst Count
  • ADAP 4
  • NEON 1
  • Target Price
  • ADAP $2.79
  • NEON $16.50
  • AVG Volume (30 Days)
  • ADAP 623.5K
  • NEON 93.6K
  • Earning Date
  • ADAP 03-05-2025
  • NEON 03-19-2025
  • Dividend Yield
  • ADAP N/A
  • NEON N/A
  • EPS Growth
  • ADAP N/A
  • NEON N/A
  • EPS
  • ADAP N/A
  • NEON N/A
  • Revenue
  • ADAP $175,041,000.00
  • NEON $3,795,000.00
  • Revenue This Year
  • ADAP $204.91
  • NEON $5.89
  • Revenue Next Year
  • ADAP N/A
  • NEON $2.61
  • P/E Ratio
  • ADAP N/A
  • NEON N/A
  • Revenue Growth
  • ADAP 146.27
  • NEON N/A
  • 52 Week Low
  • ADAP $0.53
  • NEON $1.23
  • 52 Week High
  • ADAP $2.05
  • NEON $15.00
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 40.12
  • NEON 58.88
  • Support Level
  • ADAP $0.55
  • NEON $9.26
  • Resistance Level
  • ADAP $0.61
  • NEON $10.25
  • Average True Range (ATR)
  • ADAP 0.03
  • NEON 0.57
  • MACD
  • ADAP -0.00
  • NEON 0.02
  • Stochastic Oscillator
  • ADAP 12.14
  • NEON 70.64

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in United States, Japan, South Korea, Germany, Switzerland, China, France, Sweden and Others. It derives maximum revenue from United States.

Share on Social Networks: